SLC6A18: A Potential Drug and Biomarker for Neurological and Psychiatric Disorders

Target Name: SLC6A18

NCBI ID: G348932

SLC6A18

Other Name(s): S6A18_HUMAN | Sodium channel-like protein | sodium- and chloride-dependent transporter XTRP2 | sodium-dependent neutral amino acid transporter B(0)AT3 | solute carrier family 6 (neurotransmitter transporter), member 18 | Xtrp2 | System B(0) neutral amino acid transporter AT3 | solute carrier family 6 (neutral amino acid transporter), member 18 | Solute carrier family 6 (neutral amino acid transporter), member 18 | Sodium- and chloride-dependent transporter XTRP2 | Solute carrier family 6 (neurotransmitter transporter), member 18 | system B(0) neutral amino acid transporter AT3 | Solute carrier family 6 member 18 | sodium channel-like protein | Inactive sodium-dependent neutral amino acid transporter B(0)AT3 | solute carrier family 6 member 18

SLC6A18: A Potential Drug and Biomarker for Neurological and Psychiatric Disorders

SLC6A18 (S6A18_HUMAN) is a gene that encodes a protein known as SLC6A18. SLC6A18 is a member of the SLC6A family, which is a well-known transmembrane protein family that is involved in various physiological processes in the body. SLC6A18 is expressed in many different tissues and cells throughout the body, including the brain, heart, and gastrointestinal tract.

One of the unique features of SLC6A18 is its expression pattern. SLC6A18 is predominantly expressed in the brain, where it is involved in the development and maintenance of neural circuits. In addition, SLC6A18 is also expressed in other tissues and cells throughout the body, including the heart, where it is involved in the regulation of ion channels and cardiac contractions.

SLC6A18 has also been shown to play a role in various physiological processes that are important for brain function. For example, SLC6A18 has been shown to be involved in the regulation of neurotransmitter release from nerve axons, which is important for the transmission of signals between neurons. In addition, SLC6A18 has also been shown to be involved in the regulation of cell survival and proliferation, which is important for the development and maintenance of neural circuits.

SLC6A18 is also a potential drug target. Because SLC6A18 is involved in various physiological processes that are important for brain function, it is a promising target for the development of new treatments for a variety of neurological and psychiatric disorders. For example, SLC6A18 has been shown to be involved in the regulation of neurotransmitter release from nerve axons, which is important for the transmission of signals between neurons. Therefore, compounds that can modulate SLC6A18 activity could potentially be used to treat a variety of neurological and psychiatric disorders, including depression, anxiety, and schizophrenia.

In addition to its potential as a drug target, SLC6A18 is also a potential biomarker. Because SLC6A18 is expressed in many different tissues and cells throughout the body, it can be used as a marker for various biological processes. For example, SLC6A18 has been shown to be involved in the regulation of cell survival and proliferation, which is important for the development and maintenance of neural circuits. Therefore, SLC6A18 could be used as a biomarker for the diagnosis and prognosis of various neurological and psychiatric disorders.

Overall, SLC6A18 is a gene that encodes a protein that is involved in various physiological processes throughout the body. Its unique expression pattern and involvement in the development and maintenance of neural circuits make it a promising target for the development of new treatments for a variety of neurological and psychiatric disorders. In addition, SLC6A18 is also a potential biomarker that could be used for the diagnosis and prognosis of various disorders. Further research is needed to fully understand the role of SLC6A18 in various physiological processes and its potential as a drug and biomarker.

Protein Name: Solute Carrier Family 6 Member 18

Functions: Does not show neutral amino acid transporter activity

The "SLC6A18 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC6A18 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets